Extended vs standard interval dose in Ocrelizumab treated MS patients during COVID-19 pandemic: an Italian experience
EUROPEAN JOURNAL OF NEUROLOGY
; 29:348-348, 2022.
Article
in English
| Web of Science | ID: covidwho-1965541
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Language:
English
Journal:
EUROPEAN JOURNAL OF NEUROLOGY
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS